CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 71 filers reported holding CLEARSIDE BIOMEDICAL INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $114,000 | +185.0% | 39,340 | -38.4% | 0.00% | – |
| Q3 2019 | $40,000 | -36.5% | 63,856 | -0.3% | 0.00% | – |
| Q2 2019 | $63,000 | -28.4% | 64,044 | 0.0% | 0.00% | – |
| Q1 2019 | $88,000 | -96.3% | 64,044 | -97.2% | 0.00% | -100.0% |
| Q4 2018 | $2,410,000 | -91.1% | 2,253,736 | -48.7% | 0.00% | -83.3% |
| Q3 2018 | $27,044,000 | -42.0% | 4,397,523 | +0.7% | 0.01% | -40.0% |
| Q2 2018 | $46,663,000 | -2.4% | 4,365,091 | -2.1% | 0.01% | -9.1% |
| Q1 2018 | $47,821,000 | +144.2% | 4,456,834 | +59.3% | 0.01% | +175.0% |
| Q4 2017 | $19,584,000 | -24.9% | 2,797,758 | -6.2% | 0.00% | -33.3% |
| Q3 2017 | $26,060,000 | -0.7% | 2,981,734 | +3.5% | 0.01% | 0.0% |
| Q2 2017 | $26,238,000 | +52.7% | 2,880,150 | +33.1% | 0.01% | +50.0% |
| Q1 2017 | $17,187,000 | +16.9% | 2,164,703 | +31.6% | 0.00% | 0.0% |
| Q4 2016 | $14,701,000 | -58.6% | 1,644,300 | -19.6% | 0.00% | -55.6% |
| Q3 2016 | $35,487,000 | +142.5% | 2,045,310 | -2.0% | 0.01% | +125.0% |
| Q2 2016 | $14,633,000 | – | 2,087,448 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 169,629 | $147,560 | 0.05% |
| BROWN WEALTH MANAGEMENT, LLC | 110,000 | $95,689 | 0.05% |
| Carmignac Gestion | 2,132,744 | $1,855,274 | 0.03% |
| WATER ISLAND CAPITAL LLC | 82,500 | $72 | 0.01% |
| Northeast Financial Consultants Inc | 83,000 | $72,202 | 0.01% |
| XTX Topco Ltd | 27,545 | $23,961 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 175,600 | $152,754 | 0.00% |
| Curi Wealth Management, LLC | 25,000 | $21,748 | 0.00% |
| Banque Cantonale Vaudoise | 40,000 | $35 | 0.00% |
| SYNOVUS FINANCIAL CORP | 58,071 | $50,516 | 0.00% |